Allogeneic red cell transfusion (ARCT) rate (%) and blood management costs in two series of patients undergoing lower limb arthroplasty, managed with (PIVI group) or without (control group) post-operative intravenous iron administration, according to pre-operative haemoglobin level (preOP Hb) (A) and three possible cost scenarios (ALO-1, ALO-2, ALO) (B and C) (see Methods section for further details).
*p<0.05, PIVI group vs control group.